Lanifibranor Completed Phase 2 Trials for Non-Alcoholic Steatohepatitis (NASH) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03008070 | Phase 2b Study in NASH to Assess IVA337 |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03008070 | Phase 2b Study in NASH to Assess IVA337 |